Dickmeyer Boyce Financial Management Inc. Takes Position in UnitedHealth Group Incorporated $UNH

Dickmeyer Boyce Financial Management Inc. bought a new stake in shares of UnitedHealth Group Incorporated (NYSE:UNHFree Report) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 1,341 shares of the healthcare conglomerate’s stock, valued at approximately $363,000.

Other hedge funds also recently bought and sold shares of the company. Gibbs Wealth Management purchased a new stake in shares of UnitedHealth Group during the first quarter worth about $308,000. Sei Investments Co. boosted its position in UnitedHealth Group by 32.9% during the first quarter. Sei Investments Co. now owns 728,275 shares of the healthcare conglomerate’s stock worth $197,051,000 after acquiring an additional 180,329 shares during the last quarter. Forefront Analytics LLC raised its holdings in UnitedHealth Group by 36.6% in the 1st quarter. Forefront Analytics LLC now owns 1,983 shares of the healthcare conglomerate’s stock valued at $537,000 after acquiring an additional 531 shares during the last quarter. Monograph Wealth Advisors LLC grew its position in shares of UnitedHealth Group by 6.8% in the first quarter. Monograph Wealth Advisors LLC now owns 1,174 shares of the healthcare conglomerate’s stock valued at $318,000 after purchasing an additional 75 shares during the period. Finally, American Investment Services Inc. acquired a new stake in shares of UnitedHealth Group in the first quarter worth approximately $1,029,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.

UnitedHealth Group Price Performance

Shares of NYSE UNH opened at $423.44 on Friday. The business has a 50 day moving average price of $407.46 and a two-hundred day moving average price of $345.08. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $461.62. The firm has a market cap of $384.54 billion, a PE ratio of 27.25, a price-to-earnings-growth ratio of 1.50 and a beta of 0.62. The company has a quick ratio of 0.80, a current ratio of 0.78 and a debt-to-equity ratio of 0.66.

UnitedHealth Group (NYSE:UNHGet Free Report) last released its earnings results on Thursday, July 16th. The healthcare conglomerate reported $6.38 EPS for the quarter, beating the consensus estimate of $4.94 by $1.44. UnitedHealth Group had a return on equity of 16.53% and a net margin of 3.14%.The company had revenue of $112.03 billion during the quarter, compared to analysts’ expectations of $110.81 billion. During the same period in the prior year, the business posted $4.08 EPS. The business’s revenue was up .4% on a year-over-year basis. UnitedHealth Group has set its FY 2026 guidance at 19.500-20.000 EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 19.69 earnings per share for the current fiscal year.

UnitedHealth Group Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Tuesday, June 23rd. Shareholders of record on Monday, June 15th were paid a dividend of $2.32 per share. The ex-dividend date was Monday, June 15th. This is an increase from UnitedHealth Group’s previous quarterly dividend of $2.21. This represents a $9.28 annualized dividend and a yield of 2.2%. UnitedHealth Group’s payout ratio is currently 59.72%.

Trending Headlines about UnitedHealth Group

Here are the key news stories impacting UnitedHealth Group this week:

Analyst Ratings Changes

A number of equities research analysts have issued reports on UNH shares. HC Wainwright set a $492.00 price target on UnitedHealth Group in a research report on Wednesday, May 27th. Truist Financial raised their price target on shares of UnitedHealth Group from $440.00 to $480.00 and gave the company a “buy” rating in a report on Tuesday, July 14th. Mizuho lifted their target price on shares of UnitedHealth Group from $470.00 to $493.00 and gave the company an “outperform” rating in a report on Monday. UBS Group raised their price objective on UnitedHealth Group from $460.00 to $490.00 and gave the company a “buy” rating in a research report on Friday, July 17th. Finally, Zacks Research upgraded UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a report on Monday, July 13th. Two analysts have rated the stock with a Strong Buy rating, twenty have issued a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, UnitedHealth Group has an average rating of “Moderate Buy” and an average price target of $455.92.

View Our Latest Stock Analysis on UnitedHealth Group

About UnitedHealth Group

(Free Report)

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

Recommended Stories

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.